Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak

Specchio-COVID19 Study Group

doi:10.1016/S1473-3099(21)00054-2

Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak

Specchio-COVID19 Study Group

Bloomberg School of Public Health

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	600-601
Number of pages	2
Journal	The Lancet Infectious Diseases
Volume	21
Issue number	5
DOIs	https://doi.org/10.1016/S1473-3099(21)00054-2
State	Published - May 2021

ASJC Scopus subject areas

Infectious Diseases

Access to Document

10.1016/S1473-3099(21)00054-2

Cite this

@article{814f3e374ccc423f95a0ac3e9fb8cc90,

title = "Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak",

author = "{Specchio-COVID19 Study Group} and Silvia Stringhini and Zaballa, {Mar{\'i}a Eugenia} and Javier Perez-Saez and Nick Pullen and {de Mestral}, Carlos and Attilio Picazio and Francesco Pennacchio and Ania Wisniak and Aude Richard and Helene Baysson and Andrea Loizeau and Balavoine, {Jean Fran{\c c}ois} and Didier Trono and Didier Pittet and Klara Posfay-Barbe and Antoine Flahault and Fran{\c c}ois Chappuis and Omar Kherad and Nicolas Vuilleumier and Laurent Kaiser and Azman, {Andrew S.} and Idris Guessous",

year = "2021",

month = may,

doi = "10.1016/S1473-3099(21)00054-2",

language = "English (US)",

volume = "21",

pages = "600--601",

journal = "The Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Lancet Publishing Group",

number = "5",

}

TY - JOUR

T1 - Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak

AU - Specchio-COVID19 Study Group

AU - Stringhini, Silvia

AU - Zaballa, María Eugenia

AU - Perez-Saez, Javier

AU - Pullen, Nick

AU - de Mestral, Carlos

AU - Picazio, Attilio

AU - Pennacchio, Francesco

AU - Wisniak, Ania

AU - Richard, Aude

AU - Baysson, Helene

AU - Loizeau, Andrea

AU - Balavoine, Jean François

AU - Trono, Didier

AU - Pittet, Didier

AU - Posfay-Barbe, Klara

AU - Flahault, Antoine

AU - Chappuis, François

AU - Kherad, Omar

AU - Vuilleumier, Nicolas

AU - Kaiser, Laurent

AU - Azman, Andrew S.

AU - Guessous, Idris

PY - 2021/5

Y1 - 2021/5

UR - http://www.scopus.com/inward/record.url?scp=85101283602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85101283602&partnerID=8YFLogxK

U2 - 10.1016/S1473-3099(21)00054-2

DO - 10.1016/S1473-3099(21)00054-2

M3 - Letter

C2 - 33539733

AN - SCOPUS:85101283602

SN - 1473-3099

VL - 21

SP - 600

EP - 601

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

IS - 5

ER -

Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this